乳化,乳化和乳化:解读它们在心血管疾病进展中的作用
Xuchao Hu1, Yinchang Zhang1, Qiming Zhao1
1Department of Cardiac Surgery, The Second Hospital of Lanzhou University, 730000 Lanzhou, Gansu, China.
Reviews in cardiovascular medicine
|March 6, 2026
概括
新的翻译后修饰 (PTMs),特别是化,乳化和糖化,正在成为心血管疾病 (CVDs) 的关键参与者. 了解这些表观遗传变化为诊断和治疗心脏病提供了新的途径.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 心血管研究研究心血管研究
背景情况:
- 心血管疾病 (CVD) 构成了全球健康的重大威胁,其潜在的分子机制仍在研究中.
- 表观遗传修饰,特别是翻译后修饰 (PTMs),越来越多地被认为是它们在心血管疾病发病过程中的作用.
- 传统的PTM如酸化和乙化与心血管疾病有关,但新型的乙化修饰正在出现.
研究的目的:
- 审查心血管疾病发展中的新型化修饰的机制.
- 突出在心血管疾病中肌化,乳化和糖化的作用.
- 强调了解PTM的重要性,以确定心血管疾病的新治疗标和生物标志物.
主要方法:
- 关于翻译后修饰和心血管疾病的当前科学文献的综述.
- 专注于新型的化修饰,包括化,乳化和化.
- 综合了高性能液体染色学-双重质谱学 (HPLC-MS/MS) 研究的发现.
主要成果:
- 通过先进的蛋白质组技术,已经确定了新型的化修饰,包括化,乳化和糖化.
- 这些修改代表了增强蛋白质组多样性的关键调节机制.
- 有证据表明,这些新型PTM与各种心血管疾病的发病因子之间存在密切联系.
结论:
- 新型化PTM如化,乳化和糖化都与心血管疾病发展的机制有关.
- 对这些修饰的进一步研究对于阐明心血管疾病的分子基础至关重要.
- 了解这些PTM可以导致发现新的生物标志物和治疗心血管疾病的治疗策略.
相关概念视频
01:26Atherosclerosis III: Management
538
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
538
01:26Coronary Artery Disease II: Pathophysiology
847
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
847
01:30Atherosclerosis I: Introduction
1.7K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.7K
01:27Transducer Mechanism: Enzyme-Linked Receptors
4.6K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
4.6K
01:30Coronary Artery Disease I: Introduction
1.4K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.4K
01:25Lipid Catabolism
1.2K
Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
1.2K